Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives

ABSTRACT Triterpenoids exhibit remarkable pharmacological characteristics and have garnered significant research attention, owing to their unique backbone structures and numerous modification sites. Recent advancements in supramolecular chemistry have highlighted the potential of triterpenoids to fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Zhong, Juan C. Mareque‐Rivas, Xinmiao Lan, Yu‐Xiong Su
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Aggregate
Subjects:
Online Access:https://doi.org/10.1002/agt2.70081
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849229399691362304
author Jie Zhong
Juan C. Mareque‐Rivas
Xinmiao Lan
Yu‐Xiong Su
author_facet Jie Zhong
Juan C. Mareque‐Rivas
Xinmiao Lan
Yu‐Xiong Su
author_sort Jie Zhong
collection DOAJ
description ABSTRACT Triterpenoids exhibit remarkable pharmacological characteristics and have garnered significant research attention, owing to their unique backbone structures and numerous modification sites. Recent advancements in supramolecular chemistry have highlighted the potential of triterpenoids to form organized assemblies through noncovalent interactions, affording versatile functional properties. By leveraging their unique structural characteristics and biological activities, innovative strategies can be developed to enhance the efficacy and safety of biomedical therapies. This review describes the recent advances in triterpenoids serving as (i) functional groups for aggregation‐induced emission, (ii) building blocks for self‐transportation and drug delivery, (iii) potential gelators for rational hydrogel design, and (iv) cholesterol alternatives for optimizing lipid‐based nanoparticles. The biomedical perspectives of triterpenoid‐based supramolecular assemblies and potential bottlenecks in clinical translation are also discussed, with the hope of offering insights into future research and biomedical applications.
format Article
id doaj-art-ae5c63feb5d840129ddd2dd76528e8cc
institution Kabale University
issn 2692-4560
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series Aggregate
spelling doaj-art-ae5c63feb5d840129ddd2dd76528e8cc2025-08-21T14:18:21ZengWileyAggregate2692-45602025-08-0168n/an/a10.1002/agt2.70081Supramolecular Assembly of Triterpenoids: Current State and Biomedical PerspectivesJie Zhong0Juan C. Mareque‐Rivas1Xinmiao Lan2Yu‐Xiong Su3Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Ministry of Education of China Beijing Laboratory of Biomedical Materials School of Pharmaceutical Sciences Capital Medical University Beijing ChinaDepartment of Chemistry and Centre for NanoHealth Swansea University Swansea UKBeijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Ministry of Education of China Beijing Laboratory of Biomedical Materials School of Pharmaceutical Sciences Capital Medical University Beijing ChinaDivision of Oral and Maxillofacial Surgery Faculty of Dentistry The University of Hong Kong Hong Kong SAR ChinaABSTRACT Triterpenoids exhibit remarkable pharmacological characteristics and have garnered significant research attention, owing to their unique backbone structures and numerous modification sites. Recent advancements in supramolecular chemistry have highlighted the potential of triterpenoids to form organized assemblies through noncovalent interactions, affording versatile functional properties. By leveraging their unique structural characteristics and biological activities, innovative strategies can be developed to enhance the efficacy and safety of biomedical therapies. This review describes the recent advances in triterpenoids serving as (i) functional groups for aggregation‐induced emission, (ii) building blocks for self‐transportation and drug delivery, (iii) potential gelators for rational hydrogel design, and (iv) cholesterol alternatives for optimizing lipid‐based nanoparticles. The biomedical perspectives of triterpenoid‐based supramolecular assemblies and potential bottlenecks in clinical translation are also discussed, with the hope of offering insights into future research and biomedical applications.https://doi.org/10.1002/agt2.70081hydrogelsnanotheranosticsnatural productssupramolecular assemblytriterpenoids
spellingShingle Jie Zhong
Juan C. Mareque‐Rivas
Xinmiao Lan
Yu‐Xiong Su
Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
Aggregate
hydrogels
nanotheranostics
natural products
supramolecular assembly
triterpenoids
title Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
title_full Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
title_fullStr Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
title_full_unstemmed Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
title_short Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives
title_sort supramolecular assembly of triterpenoids current state and biomedical perspectives
topic hydrogels
nanotheranostics
natural products
supramolecular assembly
triterpenoids
url https://doi.org/10.1002/agt2.70081
work_keys_str_mv AT jiezhong supramolecularassemblyoftriterpenoidscurrentstateandbiomedicalperspectives
AT juancmarequerivas supramolecularassemblyoftriterpenoidscurrentstateandbiomedicalperspectives
AT xinmiaolan supramolecularassemblyoftriterpenoidscurrentstateandbiomedicalperspectives
AT yuxiongsu supramolecularassemblyoftriterpenoidscurrentstateandbiomedicalperspectives